Sergey I. Kolesnikov

Prof. Sergey I. Kolesnikov

Personalized medicine, Scientific Center of Family Health Problems and Human Reproduction, Irkutsk, Irkutskaya Oblast’, Russia
orcid

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Open access
PDF file
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
LKL. I. Kolesnikova
L. I. Kolesnikova
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
The review presents modern views about the role of oxidative stress reactions in the pathogenesis of types 1 and 2 diabetes mellitus and their complications based on the analysis of experimental and clinical studies. The sources of increased ROS generation in diabetes are specified, including the main pathways of altered glucose metabolism, oxidative damage to pancreatic β-cells, and endothelial dysfunction. The relationship between oxidative stress, carbonyl stress, and inflammation is described. The significance of oxidative stress reactions associated with hyperglycemia is considered in the context of the “metabolic memory” phenomenon. The results of our studies demonstrated significant ethnic and age-related variability of the LPO—antioxidant defense system parameters in patients with diabetes mellitus, which should be considered during complex therapy of the disease. Numerous studies of the effectiveness of antioxidants in diabetes mellitus of both types convincingly proved that antioxidants should be a part of the therapeutic process. Modern therapeutic strategies in the treatment of diabetes mellitus are aimed at developing new methods of personalized antioxidant therapy, including ROS sources targeting combined with new ways of antioxidant delivery.

Verified
Journal Article
Open access
PDF file
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
NSNatalya Semenova
Natalya Semenova
LKLyubov Kolesnikova
Lyubov Kolesnikova
Diabetes mellitus (DM) belongs to the category of socially significant diseases with epidemic rates of increases in prevalence. Diabetic nephropathy (DN) is a specific kind of kidney damage that occurs in 40% of patients with DM and is considered a serious complication of DM. Most modern methods for treatments aimed at slowing down the progression of DN have side effects and do not produce unambiguous positive results in the long term. This fact has encouraged researchers to search for additional or alternative treatment methods. Hyperglycemia has a negative effect on renal structures due to a number of factors, including the activation of the polyol and hexosamine glucose metabolism pathways, the activation of the renin–angiotensin–aldosterone and sympathetic nervous systems, the accumulation of advanced glycation end products and increases in the insulin resistance and endothelial dysfunction of tissues. The above mechanisms cause the development of oxidative stress (OS) reactions and mitochondrial dysfunction, which in turn contribute to the development and progression of DN. Modern antioxidant therapies for DN involve various phytochemicals (food antioxidants, resveratrol, curcumin, alpha-lipoic acid preparations, etc.), which are widely used not only for the treatment of diabetes but also other systemic diseases. It has also been suggested that therapeutic approaches that target the source of reactive oxygen species in DN may have certain advantages in terms of nephroprotection from OS. This review describes the significance of studies on OS biomarkers in the pathogenesis of DN and analyzes various approaches to reducing the intensity of OS in the prevention and treatment of DN.

1 January 2017 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
SKS. I. Kolesnikov
S. I. Kolesnikov
Свободнорадикальное окисление: взгляд патофизиолога

21 June 2024 in Pathophysiology
Verified
Journal Article
Open access
PDF file
NSNatalya Semenova
Natalya Semenova
NGNadezhda Garashchenko
Nadezhda Garashchenko
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
LKLiubov Kolesnikova
Liubov Kolesnikova
Understanding how gut flora interacts with oxidative stress has been the subject of significant research in recent years. There is much evidence demonstrating the existence of the microbiome–oxidative stress interaction. However, the biochemical basis of this interaction is still unclear. In this narrative review, possible pathways of the gut microbiota and oxidative stress interaction are presented, among which genetic underpinnings play an important role. Trimethylamine-N-oxide, mitochondria, short-chain fatty acids, and melatonin also appear to play roles. Moreover, the relationship between oxidative stress and the gut microbiome in obesity, metabolic syndrome, chronic ethanol consumption, dietary supplements, and medications is considered. An investigation of the correlation between bacterial community features and OS parameter changes under normal and pathological conditions might provide information for the determination of new research methods. Furthermore, such research could contribute to establishing a foundation for determining the linkers in the microbiome–OS association.

Verified
Journal Article
Open access
PDF file
Marina A. DarenskayaMarina A. Darenskaya
Marina A. Darenskaya
KCKaren Jacqueline Cloete
Karen Jacqueline Cloete
LRLuybov Rychkova
Luybov Rychkova
Sergey I. KolesnikovSergey I. Kolesnikov
Sergey I. Kolesnikov
ZPZhanna Prokhorova
Zhanna Prokhorova
LKLyubov Kolesnikova
Lyubov Kolesnikova
Overweight and obesity are major public health concerns among children and adolescents worldwide. The most prevalent form is exogenous–constitutional obesity, which is driven by a sedentary lifestyle and an unhealthy diet in which caloric intake exceeds energy expenditure. Beyond their association with chronic disease, these factors are closely linked to deficits in cognitive development and executive functions essential for learning (including working memory, sustained attention, planning, behavioral self-regulation, and cognitive flexibility). Oxidative stress (OS), characterized by the accumulation of reactive oxygen species (ROS) in cells and extracellular fluids, is a significant potential mediator in childhood obesity and an important contributor to its comorbidities. The antioxidant defense system (AOD)’s activity largely depends on levels of trace element cofactors, which determine the body’s resistance to adverse environmental factors (the “maladaptation phenomenon”). OS and trace element deficiencies contribute to the development of morphological changes in the brain, thus serving as a critical connecting link between childhood obesity and cognitive impairment. Non-pharmacological interventions are the most accessible and effective approach for prevention and treatment. Bioactive compounds derived from food and natural plants, classified as antioxidants and phytopreparations, may represent a promising complementary approach. These compounds are most effective when used in combination with sustained lifestyle modifications in children. Research in this area can help define future directions for study and develop targeted intervention strategies in the pediatric population. The aim of this review is to examine the relationship between OS, antioxidant cofactor micronutrients, and cognitive outcomes in childhood obesity and to explore mechanisms, evidence, and therapeutic opportunities.

4 November 2025 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
NGN. E. Garashchenko
N. E. Garashchenko
NSNatalya Semenova
Natalya Semenova
NBNatalia Belkova
Natalia Belkova
ONOlga Nikitina
Olga Nikitina
ENElizaveta Novikova
Elizaveta Novikova
LKL. I. Kolesnikova
L. I. Kolesnikova
During menopause, the composition of the gut microbiota undergoes changes. At the same time, age-related deficiency of sex hormones occurs, which is considered the basis for the development of metabolic disorders, including oxidative and carbonyl stress, and this may be one of the reasons for the change in the medium mass molecules (MMM) content. Aim of the study was to establish the relationship between the MMM level and representatives of the gut microbiota in menopausal women. Material and methods . The study involved 98 women who met the following criteria: age from 45 to 69 years, amenorrhea or menstrual irregularities, anti-Müllerian hormone level less than 1.2 ng/ml. Exclusion criteria: exacerbation of chronic and presence of infectious diseases, diabetes mellitus, taking antibacterial drugs during the last three months. A quantitative assessment of the state of the gut microflora was performed using the test system Kolonoflor-16 (premium) by PCR. The MMM content was assessed in blood serum by a spectrophotometry at 238, 254, 260 and 280 nm with subsequent calculation of distribution ratio. Results. The presence of a linear relationship between the MMM content and the gut microbiome composition was revealed: an increase in the total bacterial mass, as well as the content of Bacteroides spp., Roseburia inulinivorans in fecal samples, positively correlates with the MMM level determined at all wavelengths. Bacterial indicators are also associated with distribution ratio 238/260 and 238/280. Conclusions . In menopausal women, the MMM level is interconnected with the volume of gut microbiota and the content of its individual representatives, however, changes in these indicators cannot be unambiguously interpreted as pathological, since this can be part of natural physiological processes.